Publications

1. Wells EM, Nageswara Rao AA, Scafidi J, Packer RJ. Neurotoxicity of biologically targeted agents in pediatric cancer trials. Pediatr Neurol. 2012 Apr; 46(4):212-21. 2242404
   View PubMed
2. Nageswara Rao AA, Scafidi J, Wells EM, Packer RJ. Biologically targeted therapeutics in pediatric brain tumors. Pediatr Neurol. 2012 Apr; 46(4):203-11. 2238938
   View PubMed
3. Nageswara Rao AA, Packer RJ. Impact of molecular biology studies on the understanding of brain tumors in childhood. Curr Oncol Rep. 2012 Apr; 14(2):206-12. 2216549
   View PubMed
4. Nageswara Rao AA, Kumar R, Altaf S, Gourde JA, Rodriguez V, Khan SP. Pretransplant conditioning with Campath-1H (alemtuzumab) in pediatric matched unrelated hematopoietic stem cell transplants: an institutional experience. J Pediatr Hematol Oncol. 2012 Mar; 34(2):96-100. 2209894
   View PubMed
5. Rao AA, Ye H, Decker PA, Howe CL, Wetmore C. Therapeutic doses of cranial irradiation induce hippocampus-dependent cognitive deficits in young mice. J Neurooncol. 2011 Nov; 105(2):191-8. Epub 2011 Apr 17. 2208527
   View PubMed
6. Rao AA, Laack NN, Giannini C, Wetmore C. Pleomorphic xanthoastrocytoma in children and adolescents. Pediatr Blood Cancer. 2010 Aug; 55(2):290-4. 2103384
   View PubMed
7. Nageswara Rao AA, Rodriguez V, Long ME, Winters JL, Nichols WL, Pruthi RK. Transient neonatal acquired von Willebrand syndrome due to transplacental transfer of maternal monoclonal antibodies. Pediatr Blood Cancer. 2009 Oct; 53(4):655-7. 1944216
   View PubMed
8. Nageswara Rao AA, Arteaga GM, Reed AM, Gloor JM, Rodriguez V. Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome. Pediatr Blood Cancer. 2009 Apr; 52(4):536-8. 1915188
   View PubMed